SCHEMBL13859192

SCHEMBL13859192

C[C@]1(c2cccc(OCc3ccc(Cl)cc3)c2)OC(N)=NCC1(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.41
ADAM17 P78536 1/20 0.41
MAOB P27338 4/20 0.41
MAOA P21397 2/20 0.41
NR4A2 P43354 1/20 0.39
HPD P32754 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TLR4 O00206 1/20 0.38
TLR2 O60603 1/20 0.38
ALOX5 P09917 1/20 0.37
F9 P00740 1/20 0.37
F10 P00742 1/20 0.37
APP P05067 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13859414 0.91 MAOB (0.47) BACE1ADAM17MAOBALOX5
SCHEMBL13859148 0.88 ADAM17 (0.44) ADAM17MAOBMAOA
SCHEMBL13859364 0.87 MAOB (0.43) BACE1MAOBMAOAALOX5
SCHEMBL13859319 0.80 BACE1 (0.44) BACE1ADAM17TLR4TLR2
SCHEMBL13859142 0.79 BACE1 (0.44) BACE1APP
SCHEMBL13859066 0.79 KDM1A (0.36) BACE1SMN1; SMN2APP
SCHEMBL13836393 0.78 BACE1 (0.43) BACE1ADAM17MAOBMAOAAPP
SCHEMBL13836392 0.78 BACE1 (0.43) BACE1ADAM17MAOBMAOAAPP
SCHEMBL4638746 0.69 MAOB (0.72) MAOBMAOANR4A2HPDMEN1
SCHEMBL13836047 0.67 BACE1 (0.45) BACE1ADAM17MAOBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP claimed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO claimed
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO disclosed